How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research
Cold Spring Harbor Perspectives in Medicine · 2024-05 · 14 (5) · a041384
DOI: 10.1101/cshperspect.a041384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cold Spring Harbor Perspectives in Medicine, online erschienen am 24.07.2023. Verfasst von Francisco J Sánchez Rivera und 1 weiteren Autor:innen. Beteiligte Einrichtung: David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA fsr@mit.edu lud20…. Hauptthemen laut MEDLINE: Neoplasms, Gene Editing, Disease Models, Animal, CRISPR-Cas Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 328 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Cancers arise through acquisition of mutations in genes that regulate core biological processes like cell proliferation and cell death. Decades of cancer research have led to the identification of genes and mutations causally involved in disease development and evolution, yet defining their precise function across different cancer types and how they influence therapy responses has been challenging. Mouse models have helped define the in vivo function of cancer-associated alterations, and genome-editing approaches using CRISPR have dramatically accelerated the pace at which these models are developed and studied. Here, we highlight how CRISPR technologies have impacted the development and use of mouse models for cancer research and discuss the many ways in which these rapidly evolving platforms will continue to transform our understanding of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA fsr@mit.edu lud2005@med.cornell.edu.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
- Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York 10065, USA fsr@mit.edu lud2005@med.cornell.edu.
- Department of Biochemistry, Weill Cornell Medicine, New York, New York 10065, USA.
- Department of Medicine, Weill Cornell Medicine, New York, New York 10065, USA.
ORCID-Profile: Lukas E Dow
Förderung
- NCI NIH HHS
Zitieren
APA
Sánchez Rivera, F. J., & Dow, L. E. (2024). How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research. Cold Spring Harbor Perspectives in Medicine, 14(5), a041384. https://doi.org/10.1101/cshperspect.a041384
Vancouver
Sánchez Rivera FJ, Dow LE. How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research. Cold Spring Harbor Perspectives in Medicine. 2024;14(5):a041384. doi:10.1101/cshperspect.a041384
BibTeX
@article{SnchezRivera2024,
author = {Sánchez Rivera, Francisco J and Dow, Lukas E},
title = {How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research},
journal = {Cold Spring Harbor Perspectives in Medicine},
year = {2024},
volume = {14},
number = {5},
pages = {a041384},
doi = {10.1101/cshperspect.a041384}
}
EUVIMED